- The number of separate treatment applications a patient can receive was raised from 4 to 8
- Treatment duration increased from 12 to 16 weeks
- Importantly, the MACs have maintained their insistence on well-powered, peer-reviewed clinical evidence as a prerequisite for reimbursement.
MiMedx Group Provides Update On Local Coverage Determinations; Raises Separate Treatment Applications A Patient Can Receive From 4 To 8; Increased Treatment Duration From 12 To 16 Weeks
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.